Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,380.00
+30.00 (1.28%)
At close: Sep 11, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 234.26 billion as of September 11, 2026. Its market cap has increased by 93.87% in one year.
Market Cap
234.26B
Enterprise Value
200.43B
Revenue
26.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,380.00
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 234.26B, an increase of 211.04%. That is a compound annual growth rate of 11.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 234.26B | 51.58% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 136.84B |
| GC Medical Science | 74.41B |
| GENINUS | 71.10B |
| Cytogen | 70.65B |
| Inventera | 68.98B |
| Protia | 67.62B |
| HLB Panagene | 53.45B |
| Seoulin Bioscience | 36.62B |